Contact
Mail
cccz@usz.ch
7th Zurich Immuno-Oncology Symposium
The 7th Zurich Immuno-Oncology Symposium will bring together clinicians and scientists across the cancer immunotherapy field to deepen the understanding of cancer, the immune system and immunotherapy.
Standort
USZ Kleiner Hörsaal Path C22 & Zoom
The meeting link will be provided to all registered participants prior to the meeting.
Datum
01.03.2023
Zeit
9.00 a.m. – 4.30 p.m.
Credits
SGMO 7
Program
| 9.00 a.m. | Welcome Markus G. Manz, University Hospital Zurich |
|---|---|
| Session 1: Patrick Roth | |
| 9.05 a.m. | Improving TIL-therapy in cancer George Coukos, CHUV Lausanne |
| 9.30 a.m. | PD1 resistant Melanoma: The latest drug developments Reinhard Dummer, University Hospital Zurich |
| 9.55 a.m. | Short Talk: Immunocytokines in non-melanoma skin cancer Antonio Cozzio, Hospital St. Gallen |
| 10.15 a.m. | Synergy of checkpoint inhibition and immuno-stimulation Mélanie Tichet, Hanahan Lab Lausanne |
| 10.40 a.m. | Coffee Break |
| Session 2: Markus G. Manz | |
| 11.00 a.m. | T-cell engaging Antibodies in hematologic malignancies Marion Subklewe, University Hospital Munich |
| 11.25 a.m. | Short Talk: Darpin-based, mulitple antigen-directed T-cell engagers and activators Nicolas Leupin, Chief Medical Officer Molecular Partners Zurich |
| 11.45 a.m. | Short Talk: Combined T-cell engaging and checkpoint inhibiting antibodies in plasma cell neoplasia (LocATE) Leonardo Borras, Chief Scientific Officer, CDR-Life, Zurich |
| 12.05 p.m. | Short Talk: DNA-encoded libraries for discovery of new surface targets Dario Neri, CEO of Philogen and Professor of ETH Zürich |
| 12.25 p.m. | Lunch Break |
| Session 3: Dominik Schneidawind | |
| 1.10 p.m. | New targets for CAR-T cells in hematology and oncology Michael Hudecek, University Hospital Würzburg |
| 1.30 p.m. | Universal CAR T-cells: proof of concept studies Michael Bachmann, HZDR Dresden |
| 1.55 p.m. | Short Talk: Academic virus-free CAR T-cell development Chiara Magnani, University Hospital Zurich |
| 2.20 p.m. | Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells Laura Volta, University Hospital Zurich |
| 2.40 p.m. | Coffee Break |
| Session 4: Felix Beuschlein | |
| 3.05 p.m. | Short Talk: Targeted RNA-CAR mediated immunotherapy against glioblastoma Tobias Weiss, University Hospital Zurich |
| 3.25 p.m. | Short Talk: Harnessing macrophage checkpoints to treat cancer Alexandre Theocharides, University Hospital Zurich |
| 3.45 p.m. | Microglia activation against glioblastoma Gregor Hutter, University Basel |
| 4.10 p.m. | Wrap up |
Registration
The registration is closed. You can still participate online at the following link:
Join Zoom MeetingPasscode: 704136